Louisiana State Employees Retirement System acquired a new stake in Humana Inc. (NYSE:HUM – Free Report) in the first quarter, HoldingsChannel.com reports. The fund acquired 6,100 shares of the insurance provider’s stock, valued at approximately $1,058,000.
A number of other institutional investors also recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC acquired a new stake in shares of Humana in the 4th quarter valued at approximately $202,000. Woodline Partners LP raised its position in Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after acquiring an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC raised its position in Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after acquiring an additional 452 shares in the last quarter. Cresset Asset Management LLC lifted its holdings in Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after acquiring an additional 222 shares during the period. Finally, WINTON GROUP Ltd lifted its holdings in Humana by 58.5% in the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after acquiring an additional 879 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on the stock. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Truist Financial raised their price objective on shares of Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday, June 1st. Royal Bank Of Canada reissued a “sector perform” rating on shares of Humana in a report on Monday, June 1st. Oppenheimer upgraded shares of Humana from an “outperform” rating to an “outperform” rating in a research report on Wednesday, May 20th. Finally, Robert W. Baird reduced their price target on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $293.09.
Humana Price Performance
HUM stock opened at $396.38 on Friday. The stock’s 50 day moving average price is $321.87 and its 200 day moving average price is $250.56. The firm has a market cap of $47.59 billion, a P/E ratio of 42.39, a PEG ratio of 2.26 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $415.00.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter last year, the business posted $11.58 earnings per share. Humana’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, sell-side analysts expect that Humana Inc. will post 9.03 earnings per share for the current fiscal year.
Humana Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is currently 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil JalapeƱo: An Early Step to Massive AI Growth Potential
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
